Hence, it is not surprising that the mTORC1/2 inhibitor AZD8055, which triggers MITF cytoplasmic retention, was able to decrease PGC1α expression and OXPHOS in melanoma [62]. The gene discussed is PPARGC1A; the disease is melanoma.